国际中医药转化医学研究所
胡明
发布时间:2019-06-10      来源:       点击:

undefined

胡明

胡明,博士,美国休斯顿大学药剂学教授,金沙2004路线js5杏林学者讲座教授。研究方向为药物吸收与代谢的分子机制,特别是对于黄酮成分的吸收与代谢分子机制的研究造诣非凡。他在世界性的权威杂志上发表了研究性SCI论文143篇,综述性论文30篇,论文引用5955次,H指数为46 (Google Scholar)。主编专著1部并已再版,美国专利或技术授权2项。胡明教授从事生物利用度调控机制研究,获得了美国NIH和NIC等基金的支持,承担了20余项科研项目,共获得超过1000万美元的科研经费,取得许多具有重要意义的研究成果。

教育、工作经历

1999-2000,马里兰州贝塞斯达美国国家癌症研究所代谢实验室,访问学者
1988-1990,堪萨斯州劳伦斯堪萨斯大学药物化学系,博士后
1983-1988,密歇根州安阿伯市密歇根大学药学院,博士
1978-1982,上海第一医学院(复旦大学),学士

研究方向

中药药代动力学、药物吸收和代谢及其调控机制

科研与学术工作经历

2013-至今,金沙2004路线js5,特聘讲座教授
2012-至今,十堰湖北医学院,特聘讲座教授
2007-2013,广州南方医科大学,特聘讲座教授
2004-至今,休斯顿大学药学院,教授
1997-2004,华盛顿州立大学药学院,副教授
1990-1997,华盛顿州立大学药学院,助理教授
1988-1990,堪萨斯州堪萨斯大学药学院,博士后

承担的课程

承担《药物毒理学》和《结构生物学与现代药学研究》的本科教学。

代表性论文论著

  • 1 Yu He, Lei Zhou, Song Gao, Taijun Yin, Yifan Tu, Robert Rayford, Xiaoqiang Wang, Ming Hu*. Development and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis. 148:65-72, 2018.

  • 2 Changhong Yun, Wan-Mohaiza Dashwood, Lawrence N. Kwong, Song Gao, Taijun Yin, Qinglan Ling, Rashim Singh, Roderick H. Dashwood*, Ming Hu∗. Accurate quantification of pge2 in the polyposis in rat colon (Pirc) model by surrogate analyte-based UPLC-MS/MS. Journal of pharmaceutical and biomedical analysis. 148:42-50, 2018.

  • 3 Yong Ma, Yu He, Taijun Yin, Haoqing Chen, Song Gao, and Ming Hu. Metabolism of Phenolic compounds in LPS-stimulated Raw264.7 cells can impact their Anti-inflammatory efficacy: Indication of hesperetin. Journal of agricultural and food chemistry. 66:6042-6052, 2018.

  • 4 Shufan Ge, Yingjie Wei, Taijun Yin, Beibei Xu, Song Gao, and Ming Hu*.  Transport-glucuronidation classification system and pbpk modeling: New approach to predict the impact of transporters on disposition of glucuronides. Molecular pharmaceutics. 14:2884-2898, 2017.

  • 5 Guo Ma, Ying Zhang, Wenyan Chen, Zhifang Tang, Xiaoming Xin, Ping Yang, Xiaoqin Liu, Weimin Cai*, and Ming Hu*. Inhibition of human UGT1A1-Mediated bilirubin glucuronidation by polyphenolic acids impact safety of popular salvianolic acid A/B-Containing drugs and herbal products. Molecular pharmaceutics. 14:2952-2966, 2017.

  • 6 Ming Hu*, Baojian Wu*, Zhongqiu Liu*. Bioavailability of polyphenols and flavonoids in the era of precision medicine. Molecular pharmaceutics. 14:2861-2863, 2017.

  • 7 Guangyi Yang, Shufan Ge, Rashim Singh, Sumit Basu, Katherine Shatzer, Ming Zen, Jiong Liu, Yifan Tu, Chenning Zhang, Jinbao Wei, Jian Shi, Lijun Zhu, Zhongqiu Liu, Yuan Wang, Song Gao and Ming Hu*. Glucuronidation: Driving factors and their impact on glucuronide disposition. Drug metabolism reviews. 49:105-138, 2017.

  • 8 Jianfei Peng, Ming Hu, Song Guo, Zhuofei Du, Jing Zheng, Dongjie Shang, Misti Levy Zamora, Limin Zeng, Min Shao, Yu Sheng Wu, Jun Zheng, Yuan Wang, Crystal R.Glen, Donald R.Collins, Mario J.Molina, and Renyl Zhang*. Markedly enhanced absorption and direct radiative forcing of black carbon under polluted urban environments. Proceedings of the National Academy of Sciences of the United States of America. 113:4266-4271, 2016.

  • 9 Meifang Wang, Guangyi Yang, Yu He, Beibei Xu, Ming Zeng, Taijun Yin, Song Gao, and Ming Hu*. Establishment and use of new mdck ii cells overexpressing both ugt1a1 and mrp2 to characterize flavonoid metabolism via the glucuronidation pathway. Molecular nutrition & food research. 60:1967-1983, 2016.

  • 10 Min Zeng#, Rongjin Sun#, Sumit Basu, Yong Ma, Shufan Ge, Taijun Yin, Song Gao, Jun Zhang*, and Ming Hu. Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides. Molecular nutrition & food research. 60:1006-1019, 2016.

上一条:龚凌志

下一条:王彩艳